Avenue Therapeutics, Inc.
ATXI
$0.58
-$0.01-1.70%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.40M | -- | -- | -- | -- |
| Total Revenue | 1.40M | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.40M | -- | -- | -- | -- |
| SG&A Expenses | 915.00K | 1.49M | 1.03M | 829.00K | 1.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.11M | 1.91M | 1.60M | 3.16M | 2.82M |
| Operating Income | 297.00K | -1.91M | -1.60M | -3.16M | -2.82M |
| Income Before Tax | 329.00K | -1.86M | -1.56M | -3.09M | -2.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 329.00K | -1.86M | -1.56M | -3.09M | -2.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.00K | 6.00K | 15.00K | 11.00K | 9.00K |
| Net Income | 335.00K | -1.85M | -1.54M | -3.08M | -2.69M |
| EBIT | 297.00K | -1.91M | -1.60M | -3.16M | -2.82M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.11 | -0.62 | 3.83 | -1.92 | -6.43 |
| Normalized Basic EPS | 0.07 | -0.39 | -0.51 | -1.20 | -1.50 |
| EPS Diluted | 0.11 | -0.62 | 3.83 | -1.92 | -6.43 |
| Normalized Diluted EPS | 0.07 | -0.39 | -0.51 | -1.20 | -1.50 |
| Average Basic Shares Outstanding | 3.18M | 2.97M | 1.90M | 1.60M | 1.12M |
| Average Diluted Shares Outstanding | 3.18M | 2.97M | 1.90M | 1.60M | 1.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |